The findings reviewed by GME stated that the Global Helicobacter Pylori Diagnostics Market would grow at a CAGR value of 7.4 percent from 2021 to 2026. With drastically increasing advancements and less complex diagnostic processes, the reliability and demand for helicobacter pylori diagnostics are increasing. Also, most developing countries have unsanitary water services and facilities, along with a lack of awareness about personal care; the helicobacter pylori bacterial infection is increasing, thus accelerating the growth within the market.
Browse 159 Market Data
Tables and 119 Figures spread through 189 Pages and in-depth TOC on “Helicobacter Pylori Diagnostics Market - Forecast to 2026”
https://www.globalmarketestimates.com/market-report/global-helicobacter-pylori-diagnostics-market-3180
By Technology (Immunoassays, POC, and Molecular Diagnostics), By End-User (Hospitals, Diagnostics
Laboratories, and Clinics), By Region
(North America, Europe, Asia Pacific, MEA, and CSA); End-User Landscape,
Company Market Share Analysis, and Competitor Analysis
Key Market Insights
·
Growing contagious
disease frequency, enhanced cost-effectiveness of helicobacter pylori infection
detection, and increased public knowledge about pathogens are the main driving
forces.
·
Immunoassay is
preferred and utilized the most for diagnosing the presence of helicobacter
pylori bacteria, thus holding the most significant share within the market.
·
The hospitals are
analyzed to hold the largest share within the Helicobacter Pylori diagnostics
market.
·
North America is
presumed to dominate because of advanced & developed medical &
healthcare sectors.
·
Alpha
Laboratories, Biohit, Bio-Rad Laboratories, CorisBioConcept, Thermo Fisher
Scientific, Epitope Diagnostics, Quest Diagnostics, Meridian Bioscience, F.
Hoffmann-La Roche, and CertestBiotec are few prominent competitors in the
market.
Browse
the Report @ https://www.globalmarketestimates.com/market-report/global-helicobacter-pylori-diagnostics-market-3180
Technology Outlook (Revenue, USD Billion, 2021-2026)
·
Immunoassays
·
POC
·
Molecular
Diagnostics
End-User Outlook (Revenue, USD Billion, 2021-2026)
·
Hospitals
·
Diagnostics
Laboratories
·
Clinics
Regional Outlook
(Revenue, USD Billion, 2021-2026)
North America
- The US.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
Asia Pacific
Central & South America
- Brazil
- Argentina
- Rest of CSA
Middle East & Africa
- Saudi Arabia
- UAE
- Rest of MEA
Contact:
Tracy Simon
Email
address: tracy.simon@globalmarketestimates.com
Phone
Number: +16026667238
Website:
https://www.globalmarketestimates.com/
No comments:
Post a Comment